Wednesday, AbbVie Inc. (ABBV) announced the appointment of Roopal Thakkar as the executive vice president of research and development and chief scientific officer. This comes as Thomas Hudson, the current senior vice president and chief scientific officer of global research at AbbVie, is set to retire.
In his new position, Thakkar will oversee AbbVie's global R&D organization, which comprises of over 14,000 team members.He will lead the company's six major R&D centers of excellence situated in the United States, Germany, and Japan.
Thakkar, who currently serves as the senior vice president and chief medical officer of global therapeutics, first joined the company in 2003 through the Physician Development Program.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.